Daegu, South Korea

Sung Bo Kyung

This inventor holds 1 USPTO granted patent. Top assignee: Other. Active years: 2024.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Sung Bo Kyung. Retrieved from https://idiyas.com/inventor/sung-bo-kyung

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 5.0

ph-index = 1


Company Filing History:

goldMedal1 out of 834,513 
Other
 patents

Years Active: 2024

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Sung Bo Kyung

Introduction

Sung Bo Kyung is a notable inventor based in Daegu, South Korea. He has made significant contributions to the field of pharmaceuticals, particularly in the development of anti-inflammatory drugs. His work is characterized by a focus on compounds that can serve multiple therapeutic purposes.

Latest Patents

Sung Bo Kyung holds 1 patent for a compound that functions as an anti-inflammatory agent and a cyclooxygenase-2 inhibitor. This innovative compound can also be utilized as a therapeutic agent for brain diseases and as an MRI contrast medium. The compound is represented by a specific chemical formula, showcasing its potential applications in medical treatments.

Career Highlights

Throughout his career, Sung Bo Kyung has demonstrated a commitment to advancing medical science through his inventions. His research has led to the development of compounds that address significant health issues, particularly in the realm of inflammation and neurological disorders.

Collaborations

Sung Bo Kyung has worked alongside talented colleagues, including Yong Min Chang and Seungtae Woo. Their collaborative efforts have contributed to the success of his research and the advancement of innovative solutions in the pharmaceutical industry.

Conclusion

Sung Bo Kyung's contributions to the field of pharmaceuticals highlight the importance of innovation in developing effective medical treatments. His work continues to inspire future advancements in the industry.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…